ProCAncer-I at the International Cancer Imaging Society Meeting in Boston

Published on: September 16, 2022
Categories: News

Really glad to have been a part of the 21st Annual Teaching course at the International Cancer Imaging Society Meeting in Boston! The meeting had the title: “Cancer Imaging: An all-inclusive specialty” and was held on Monday 12th to Wednesday 14th September 2022 at Hotel Commonwealth, 500 Commonwealth Avenue, Boston

Prof Mu Koh from The Royal Marsden Hospital and Dr Nickolas Papanikolaou from Champalimaud Foundation organised a Workshop with the title:

Practice-oriented Cancer Imaging AI technology applications for clinical use

During the workshop, they focused on explaining questions that the end user should ask the AI developer before choosing and using an AI model.

Highlights

The brand effect: how different MRI machines trip up AI

The brand effect: how different MRI machines trip up AI

Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...

Dissemination Event of the ProCAncer-I Project in Vienna

Dissemination Event of the ProCAncer-I Project in Vienna

We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025.  Date: 26 February 2025  Time: 15:00 – 16:00  Location: ECR 2025, Vienna, Austria (conference...

ProCAncer-I at the ECR 2025 in Vienna

ProCAncer-I at the ECR 2025 in Vienna

ProCAncer-I will organise a Dedicated Session on the project during the European Congress of Radiology 2025 on the 26th of February 2025, at 15.00-16.00, with the title "ProCAncer-I: an AI platform integrating multiparametric MRI and AI models" where we will present...

Stay in touch!